Carregant...
Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief Report
We examined whether neuropsychiatric symptoms (NPS) interact with cerebrospinal fluid (CSF) biomarkers (amyloid-β(42) [Aβ(42)], tau, phosphorylated tau(181) [ptau(181)], tau/Aβ(42), and ptau(181)/Aβ(42)) of Alzheimer's disease pathology to predict driving decline among cognitively-normal older...
Guardat en:
| Publicat a: | J Alzheimers Dis |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5555740/ https://ncbi.nlm.nih.gov/pubmed/28453487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-170067 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|